Celularity (CELUW) Other Non-Current Liabilities (2019 - 2025)

Celularity (CELUW) reported Other Non-Current Liabilities of $1.5 million for Q4 2025, down 52.67% year-over-year from $3.3 million in Q4 2024, and down 56.16% quarter-over-quarter from $3.5 million in Q3 2025.

Celularity (CELUW) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends

Celularity (CELUW) has 7 years of Other Non-Current Liabilities data on file, last reported at $1.5 million in Q4 2025.

  • Other Non-Current Liabilities for Q4 2025 came in at $1.5 million, down 52.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (down 52.67% YoY), and the FY2025 annual result was $1.5 million, down 52.67% from the prior year.
  • Other Non-Current Liabilities retreated to $1.5 million in Q4 2025 per CELUW's latest filing, from $3.5 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $255.5 million in Q3 2021 and troughed at $283000.0 in Q3 2024.
  • A 5-year average of $36.9 million and a median of $8.1 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities plunged 99.72% in 2023, then soared 4645.91% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $232.2 million in 2021, then sank by 54.38% to $105.9 million in 2022, then sank by 99.72% to $294000.0 in 2023, then soared by 1010.2% to $3.3 million in 2024, then sank by 52.67% to $1.5 million in 2025.
  • Business Quant data shows CELUW's Other Non-Current Liabilities at $1.5 million in Q4 2025, $3.5 million in Q3 2025, and $8.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Celularity - - -3.27 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.55 Mn
Sep 30, 2025 3.52 Mn
Jun 30, 2025 8.78 Mn
Mar 31, 2025 8.07 Mn
Dec 31, 2024 3.26 Mn
Sep 30, 2024 283,000.00
Jun 30, 2024 8.09 Mn
Mar 31, 2024 15.09 Mn
Dec 31, 2023 294,000.00
Sep 30, 2023 1.61 Mn
Jun 30, 2023 1.61 Mn
Mar 31, 2023 318,000.00
Dec 31, 2022 105.95 Mn
Sep 30, 2022 14.09 Mn
Jun 30, 2022 23.43 Mn
Mar 31, 2022 1.90 Mn
Dec 31, 2021 232.22 Mn
Sep 30, 2021 255.52 Mn
Jun 30, 2021 29.35 Mn
Mar 31, 2021 23.79 Mn